Treatment of immune thrombocytopenia (ITP) usually involves long‐term use of immunosuppressive corticosteroids and splenectomy. However, these treatments often have side effects in patients. The Mongolian medicine Qishunbaolier (QSBLE) has a high curative effect, reduces the chances of relapse, and has no obvious side effects. This study was designed to identify potential therapeutic targets of QSBLE for treating ITP.

中文翻译：

---

基于iTRAQ的免疫性血小板减少症患者免疫性血小板减少症治疗前后的定量蛋白质组学分析

免疫性血小板减少症 (ITP) 的治疗通常涉及长期使用免疫抑制性皮质类固醇和脾切除术。然而，这些治疗通常会对患者产生副作用。蒙药齐顺保利尔（QSBLE）疗效高，减少复发机会，无明显副作用。本研究旨在确定 QSBLE 治疗 ITP 的潜在治疗靶点。